Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells.

Oncogene
P PramoonjagoChristopher A Moskaluk

Abstract

Microarray RNA gene expression profiling analysis has shown that Sox4 (Sry-related high mobility group (HMG) box 4) is one of the most upregulated genes in adenoid cystic carcinoma (ACC), relative to non-neoplastic tissue of origin. Here, we show that Sox4 protein is similarly upregulated in ACC by immunohistochemistry of 28 primary cancers and 20 normal tissues. To elucidate the functional significance of these findings, RNA interference (RNAi)-mediated RNA silencing was used to downregulate Sox4 expression in the ACC-derived cell line, ACC3. With confirmed knockdown of Sox4 protein, cell viability was reduced by 51%, with a corresponding increase of apoptosis to 85% as compared to 12% in controls. Apoptosis was confirmed by cell morphology, DNA fragmentation and flow cytometry. Cells could be rescued from the proapoptotic effects of Sox4 RNAi by co-transfection with a construct expressing functional Sox4. Microarray gene expression profiling of RNAi knockdown experiments shows that downregulation of Sox4-modulated expression of critical genes involved in apoptosis and cell cycle control. Overall, our findings suggest that Sox4 contributes to the malignant phenotype of ACC cells by promoting cell survival.

References

Jan 1, 1993·Mammalian Genome : Official Journal of the International Mammalian Genome Society·C J FarrP N Goodfellow
Sep 1, 1996·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·R MunakataT Saku
Feb 26, 1999·Nucleic Acids Research·M Wegner
Jun 8, 1999·Japanese Journal of Cancer Research : Gann·K ToyoshimaT Saku
Jul 20, 1999·Biology of Reproduction·S M Hunt, C L Clarke
Sep 3, 1999·Mechanisms of Development·B CapelE M Eicher
May 18, 2001·Nature·G I Evan, K H Vousden
Jun 8, 2001·The Journal of Biological Chemistry·S Van HuffelR Beyaert
Aug 22, 2001·The Journal of Biological Chemistry·D K PandaD Goltzman
May 11, 2002·Nature Reviews. Cancer·Frederik H Igney, Peter H Krammer
Aug 20, 2002·Nature Genetics·Takeshi SuzukiNeal G Copeland
Aug 20, 2002·Nature Genetics·Anders H LundMaarten van Lohuizen
Oct 9, 2002·The American Journal of Pathology·Henry F FriersonGarret M Hampton
May 20, 2003·Nature Biotechnology·Aimee L JacksonPeter S Linsley
Aug 28, 2003·Nature Cell Biology·Carol A SledzBryan R G Williams
Mar 12, 2004·Genes & Development·John G Doench, Phillip A Sharp
Apr 28, 2004·Developmental Biology·Lixin KanJohn A Kessler
Jun 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Daniel R RhodesArul M Chinnaiyan
Jul 1, 2004·The Journal of Steroid Biochemistry and Molecular Biology·David GoltzmanGeoffrey N Hendy
Aug 12, 2004·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·H F LuJ G Chung
Nov 4, 2004·Biochemical and Biophysical Research Communications·Eun-Hye HurHyangshuk Rhim
Aug 25, 2005·Cold Spring Harbor Symposia on Quantitative Biology·I Muyrers-ChenM van Lohuizen
Jan 19, 2006·Oncogene·A MiltonN B La Thangue

❮ Previous
Next ❯

Citations

Aug 9, 2011·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Huahua CaiJiawen Li
Jul 3, 2010·Nature Communications·Pallavi BhattaramVéronique Lefebvre
Feb 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Xin PanXue-Min Zhang
Jan 21, 2009·Human Molecular Genetics·Pedro P MedinaMontse Sanchez-Cespedes
Jan 17, 2009·Cancer Research·Christopher D ScharerCarlos S Moreno
Feb 14, 2009·PLoS Genetics·Suganthi ChittaranjanSharon M Gorski
Feb 28, 2013·International Journal of Molecular Sciences·Yongzhao ZhuXiaoming Liu
Mar 11, 2009·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Nikolaos G NikitakisJohn J Sauk
Mar 11, 2009·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Nikolaos G NikitakisJohn J Sauk
Oct 20, 2012·Cellular and Molecular Life Sciences : CMLS·Seyed Mehdi JafarnejadGang Li
Jul 28, 2012·Expert Opinion on Therapeutic Targets·Sandra D Castillo, Montse Sanchez-Cespedes
Apr 12, 2008·Expert Review of Anticancer Therapy·Sreenivasa R Chandana, Barbara A Conley
Sep 10, 2015·International Journal of Oncology·Yulong LiuQingsan Zhu
Jun 23, 2015·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Ling LiQiao Zhou
Aug 8, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J ChenB Q Lai
Oct 19, 2011·Head & Neck·Jia LiuPatrick K Ha
May 28, 2011·International Journal of Cancer. Journal International Du Cancer·Holger HeynCarmela Beger
Jun 1, 2010·American Journal of Hematology·Ulrika AndréassonSara Ek
Apr 25, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiao-Shan MinShi Chang
May 15, 2015·Biochemical and Biophysical Research Communications·Sang-Min JangKyung-Hee Choi
Oct 19, 2010·The American Journal of Pathology·Seyed Mehdi JafarnejadGang Li
May 7, 2015·Oral Oncology·Andrés Coca-PelazAlfio Ferlito
Feb 18, 2011·Gut Microbes·Ravi Mangal Patel, Patricia W Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.